8Mês
Fundamental Analysis (The Financial "Macro") 📊
The earnings were released yesterday evening, and the market is euphoric today:
Moat: They hold a global monopoly on Cystic Fibrosis (CF) treatment. No one can touch them there. It is a guaranteed "cash-printing machine."
Growth: Revenue rose 10% in the last quarter.
2026 Guidance: They project revenues of $13 Billion for this year.
War Chest: They have $12.3 Billion in Cash. It is a financial fortress (as secure as your Apple or Google positions).
Technical Analysis (The Entry Point) 📈
Current Price: ~$500.36 (Up ~6% today).
The Signal: The stock just triggered a "Breakout" (broke through the $485 resistance level).
RSI: It was at 49 (neutral) before today. With this surge, it should be in the 60-65 zone. It is not overbought (>70); it is in Momentum. This is the point where institutional traders enter to ride the wave.
The earnings were released yesterday evening, and the market is euphoric today:
Moat: They hold a global monopoly on Cystic Fibrosis (CF) treatment. No one can touch them there. It is a guaranteed "cash-printing machine."
Growth: Revenue rose 10% in the last quarter.
2026 Guidance: They project revenues of $13 Billion for this year.
War Chest: They have $12.3 Billion in Cash. It is a financial fortress (as secure as your Apple or Google positions).
Technical Analysis (The Entry Point) 📈
Current Price: ~$500.36 (Up ~6% today).
The Signal: The stock just triggered a "Breakout" (broke through the $485 resistance level).
RSI: It was at 49 (neutral) before today. With this surge, it should be in the 60-65 zone. It is not overbought (>70); it is in Momentum. This is the point where institutional traders enter to ride the wave.
•
11
•
@Mrap_ Thank you my dear
••
7Mês
8% today 😜
••